Skip to main content

Sitagliptin Dose Determination Study

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Sitagliptin Dose Determination Study

Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer

A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy

Needle-Guided vs Free-Hand Technique in Performing Brachial Plexus Blockade

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Needle-Guided vs Free-Hand Technique in Performing Brachial Plexus Blockade

Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy

Risk Stratification After Acute Myocardial Infarction With Cardiac MRI

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Risk Stratification After Acute Myocardial Infarction With Cardiac MRI

The Human Epilepsy Project

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about The Human Epilepsy Project

Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 119
  • Page 120
  • Page 121
  • Page 122
  • Page 123
  • Page 124
  • Page 125
  • Page 126
  • Page 127
  • …
  • Next page Next
  • Last page Last
Subscribe to